Inhaled nitric oxide (NO): A concise review

Acta Anaesthesiologica Scandinavica, Supplement

Volumn 42, Issue 112, 1998, Pages 240-243

  Eisenmenger, A ^a   Lorber, C ^a   Roder G ^a   Klimscha, W ^a   Germann, P ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN;

ADULT RESPIRATORY DISTRESS SYNDROME; BLOOD TOXICITY; CONFERENCE PAPER; DRUG INDICATION; DRUG MECHANISM; HUMAN; INHALATION ANESTHESIA; INTENSIVE CARE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0031720285     PISSN: 05152720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Arnold WP, Aldred R, Murad F. Cigarette smoke activates guanylate cyclase and increases guanosine 3',5'-monophosphate in tissues. Science 1977:198: 934-936.
2. Klass DJ. Cigarette smoke exposure in vivo increases cyclic GMP in rat lung. Arch Environ Health 1980: 35: 347-350.
3. Furchgott RF, Zawadzki IV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980: 288: 373-376.
4. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 1987: 327: 524-526.
5. Ignarro LI, Buga GM, Wood KS, Byrus RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sei USA 1987: 84: 9265-9269.
6. Higenbottam T, Pepke-Zaba J, Scott J, Woolman P, Coutts C, Wallwork W. Inhaled "endothelium-derived relaxing factor" (EDRF) .in primary pulmonary hypertension (PPH). Am Rev Respir Dis 1988:137(Suppl): 107.
7. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: A selective pulmonary vasodilator revealing hypoxic pulmonary vasoconstriction. Circulation 1991: 83: 2037-2047.
8. Frostell C, Blomqvist H, Lundberg J, Hedenstierna G, Zapol WM. Inhaled nitric oxide dilates human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 1991: 75: A984.
9. Falke K, Rossaint R, Pison U, Slama K, Lopez F Santak, Zapol WM. Inhaled nitric oxide selectively reduces pulmonary hypertension in severe ARDS and improves gas exchange as well as right heart ejection fraction - a case report. Am -Rev Respir Dis 1991:143(Suppl.): A248.
10. Mellion BT, Ignarro LJ, Myers CB, Ohlstein EH, Ballot BA, Hyman AL, Kadowitz PJ. Inhibition of human platelet ag-gregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmncol 1983: 23: 653-654.
11. Roberts JD, Polaner DM, Todres ID, Lang P, Zapol WM. Inhaled nitric oxide (NO): A selective pulmonary vasodilator for the treatment of persistent pulmonary hypertension of the newborn (PPHN). Circulation 1991: 84(Suppl. II): 11-321.
12. Huffman GM, Ross GA, Day SE, Rice TB, Neun LD. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygénation in persistent pulmonary hypertension of the newborn. Crit Care Med 1997: 25: 352-359.
13. Germann P. A new system for differentiated application and continuous measurement of nitric oxide and nitrogen dioxide. Anesthesiology 1994: 81: A574.
14. Krebs C, Escuyer M, Urak G, Zimpfer M, Germann P. Technological basis for nitric oxide application and environmental security. Ada Anaesthesia] Scand 1996: 40: 84-87.
15. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993: 328: 399-405.
16. Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ. Long-term inhalation with evaluated low doses of nitric oxide for improvement of oxygénation in patients with adult respiratory distress syndrome. Intensive Care Med 1993: 19: 443-449.
17. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygénation and pulmonary-hypertension in patients with adult respiratory distress syndrome. E»r / Clin Invest 1993: 23: 499-502.
18. Germann P, Balassa A, Reeder G, Kaider A, Schlag G, Zimpfer M, Sladen R. Effects of inhaled nitric oxide and extracorporeal membrane oxygénation (ECMO) on oxygénation, hemodynamics, and lymphatic drainage in oleic acid lung injury in sheep. Crit Care Med 1997: 25(11): 1881-1887.
19. Radomski MW, Moncada S. Regulation of vascular homeostasis by nitric oxide. Thrombosis and Haeinostasis 1993: 70: 36-11.
20. Samama CM, Diaby M, Fellahi JL, Mdhafar A, Eyraud D, Arock M, Guillosson JJ, Coriat P, Rouby CC. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1995: 83: 56-65.
21. Högmann M. Bleeding time prolongation and NO inhalation. Lancet 1993: 341: 1664-1665.
22. Högmann M. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Ada Physiol Scand 1994:151:125-129.
23. Cries A, Motsch J, Penk S, Bauer H, Weimann J, Martin E. Inhaliertes Stickstoffmonoxid beeinfluβt die Blutungszeit bei Männern und Frauen unterschiedlich. Der Anästhesist 44(Suppl. 2): M009-M003.
24. Shernan S, Fox J, Body S, Morse D, Magnani B. Inhaled nitric oxide does not inhibit platelets in healthy human volunteers. Anesthesiology 1996: 85: A139.
25. Luhr O, Nathorst Westfelt U, Lundin S, Wickerts CJ, Stiernstrom H, Berggren L, Aardal S, Johansson LA, Stenqvist O, Rudberg U, Lindh A, Bindslev L, Martling CR, Hornbaek V, Frostell C. A retrospective analysis of nitric oxide inhalation in patients with severe acute lung injury in Sweden and Norway 1991-1994. Ada Anaesthesiol Scand 1997: 41(10): 1233-1234.
26. Hallman M, Waffarn F, Bry K et al. Surfactant dysfunction after inhalation of nitric oxide./ Appl Physiol 1996: 80: 20262034.
27. Haddad IY, Crow JP, Hu P, Ye Y, Beckman J, Matalon S. Concurrent generation of nitric oxide and Superoxide damages surfactant protein A. Am J Physiol 1994: 267: L242-349.
28. Sitbon O, Brenot F, Denjean A et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995:151: 384-389.
29. Roberts JDJ, Fineman JR, Morin FCI et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl f Med 1997: 336: 605-610.
30. Roberts JJ, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993: 87: 447-453.
31. Matthay MM et al. Just say NO to inhaled nitric oxide for the acute respiratory distress syndrome. Crit Care Med 1998: 26(1): Editorial.
32. Zapol WM. Nitric oxide inhalation in acute respiratory distress syndrome: It works, but can we prove it? Crit Care Med 1998: 26(1): Editorial.
33. Adnot S, Kouyoumdjian C, Defouilloy C, Andrivet P, Sediame S, Herigault R, Fratacci MD. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 1993: 148(2): 310-316.
34. Germann P et al. Addition of nitric oxide to oxygen improves cardiopulmonary functions in patients with severe chronic obstructive pulmonary disease. Chest 1998: in press.
35. Gillart T, Bazin JE, Cosserant B, Guelon D, Aigouy L, Mansoor O, Schoeffler P. Combined nitric oxide inhalation, prone position and almitrine infusion improve oxygénation in severe ARDS. Can J Anaestli 1998: 45(5) Part 1: 402-409.
36. Cuthbertson BH, Dellinger P, Dyar OJ, Evans TE, Higenbottam T, Latimer R, Payen D, Stott SA, Webster NR, Young JD. UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS. Intensive Care Med 1997: 23(12): 1212-1218.